The FDA has approved Ionsys, a fentanyl iontophoretic transdermal system from the Medicines Co., according to a Medscape report.
Ionsys is the first needle-free, patient-controlled fentanyl delivery system designed for postoperative pain management.
Ionsys' efficacy was examined in three placebo-controlled trials. The device's safety was examined in an additional three placebo-controlled trials and four active-controlled randomized trials.
Ionsys is expected to become available in the United States later this year, according to the report.